News
The achievement of that goal in India, which ranks third in obesity numbers after the US and China, will shatter the record ...
Greg Abbott’s veto of a bill that his lieutenant governor supported underscores the patchwork nature of regulation of ...
Unites Pharma Marketing, PR & Communications, New Product Planning & Commercialization, and Medical Affairs Communities; ...
Newsweek's AI Impact Award winners share how they measure success and guarantee outcomes: setting themselves apart in a ...
TimesSquare Capital Management, an equity investment management company, released its “U.S. Small Cap Growth Strategy” ...
Explore innovations in industrial biopolymers and their role in creating sustainable, eco-friendly alternatives for packaging ...
Fueled by a sustained boom in sales of its diabetes and obesity products, Eli Lilly will become the world’s top-seller of prescription drugs by 2030 and will hold the top rung by a wide margin. | ...
For the life sciences sector, the new initiatives are meant to work in concert with the upcoming 10-year plan for the ...
Blending Bold Strategy with Proven Market Access and Health Economics Expertise to Unlock Asset Value YARDLEY, Pa. and LONDON, June 23, 2025 /PRNewswire/ ...
8hOpinion
Zacks Investment Research on MSNHIMS Stock Crashes 30% in a Day: Time to Buy the Dip?Hims & Hers Health (HIMS) has been one of the market’s standout growth stocks in recent years. The company has successfully ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results